Exosomal MIR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Xiaohong ^a   Gu, Haitao ^a   Qin, Dongze ^a,b   Yang, Liwang ^a,c   Huang, Wei ^a   Essandoh, Kobina ^a   Wang, Yigang ^a   Caldwell, Charles C ^a   Peng, Tianqing ^d   Zingarelli, Basilia ^e   Fan, Guo Chang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c SHANXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; LIPOPOLYSACCHARIDE; MICRORNA; MIRN223 MICRORNA, MOUSE; SEMAPHORIN 3A; STAT3 PROTEIN;

ANIMAL; CARDIAC MUSCLE CELL; CELL DEATH; COMPLICATION; DISEASE MODEL; EXOSOME; FEMALE; GENETICS; HEART DISEASES; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MICROBIOLOGY; MORTALITY; MOUSE; PATHOPHYSIOLOGY; SEPSIS;

ANIMALS; CELL DEATH; CYTOKINES; DISEASE MODELS, ANIMAL; EXOSOMES; FEMALE; HEART DISEASES; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, KNOCKOUT; MICRORNAS; MYOCYTES, CARDIAC; SEMAPHORIN-3A; SEPSIS; STAT3 TRANSCRIPTION FACTOR;

EID: 84941104852     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13721     Document Type: Article

References (47)

1. Iskander, K. N. et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 93, 1247-1288 (2013).
2. Romero-Bermejo, F. J. et al. Sepsis-induced cardiomyopathy. Curr Cardiol Rev. 7, 163-183 (2011).
3. Németh, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E (2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 15, 42-49 (2009).
4. Mei, S. H. et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 182, 1047-1057 (2010).
5. Weil, B. R. et al. Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia. Shock. 36, 235-241 (2011).
6. Anderson, P. et al. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 62, 1131-1141 (2013).
7. Kusadasi, N., Groeneveld, A. B. A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis. Shock. 40, 352-357 (2013).
8. Prockop, D. J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276, 71-74 (1997).
9. Krasnodembskaya, A. et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol. 302, L1003-1013 (2012).
10. Vlassov, A. V., Magdaleno, S., Setterquist, R., Conrad, R. Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 1820, 940-948 (2012).
11. Ailawadi, S., Wang, X., Gu, H., Fan, G. C. Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta. 1852, 1-11 (2015).
12. Chiba, M., Kimura, M., Asari, S. Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep. 28, 1551-1558 (2012).
13. Wang, X. et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol. 74, 139-150 (2014).
14. Lai, R. C. et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4, 214-222 (2010).
15. vanKoppen, A. et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One. 7, e38746 (2012).
16. Lee, C. et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 126, 2601-2611 (2012).
17. Li, T. et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22, 845-854 (2013).
18. Xin, H. et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 31, 2737-2746 (2013).
19. Ibrahim, A. G., Cheng, K., Marbán, E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2, 606-619 (2014).
20. Ismail, N. et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 121, 984-995 (2013).
21. Taïbi, F. et al. miR-223: An inflammatory oncomiR enters the cardiovascular field. Biochim Biophys Acta. 1842, 1001-1009 (2014).
22. Wang, X. et al. Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis. Biochim Biophys Acta. 1842, 701-711 (2014).
23. Wang, X. et al. Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. J Mol Cell Cardiol. 47, 382-390 (2009).
24. Crouser, E. D. Re-defining the roles of apoptosis pathways during sepsis. Crit Care Med. 33, 670-672 (2005).
25. Buerke, U. et al. Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 29, 497-503 (2008).
26. Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 319, 1244-1247 (2008).
27. Li, J. et al. Exosomes mediate the cell-to-cell transmission of IFN-?-induced antiviral activity. Nat Immunol. 14, 793-803 (2013).
28. Raposo, G. et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 183, 1161-1172 (1996).
29. Chen, Q. et al. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1? production in macrophages by targeting STAT3. PLoS One. 7, e42971 (2012).
30. Wen, H., Lei, Y., Eun, S. Y., Ting, J. P. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor-and sepsis-induced cytokine storm. J Exp Med. 207, 2943-2957 (2010).
31. Matsukawa, A. et al. Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J Immunol. 171, 6198-6205 (2003).
32. Greenhill, C. J. et al. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol. 186, 1199-1208 (2011).
33. Halkein, J. et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 123, 2143-2154 (2013).
34. Yu, B. et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol. 182C, 349-360 (2014).
35. Gatti, S. et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial. Transplant. 26, 1474-1483 (2011).
36. Wang, X. et al. Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells. 27, 3021-3031 (2009).
37. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 451, 1125-1129 (2008).
38. Lu, H., Buchan, R. J., Cook, S. A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res. 86, 410-420 (2010).
39. Dorhoi, A. et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 123, 4836-4848 (2013).
40. Haneklaus, M. et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1? production. J Immunol. 189, 3795-3799 (2012).
41. Zhuang, G. et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation. 125, 2892-2903 (2012).
42. Wang, H. et al. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One. 7, e38885 (2012).
43. Manukyan, M. C. et al. Female stem cells are superior to males in preserving myocardial function following endotoxemia. Am J Physiol Regul Integr Comp Physiol. 300, R1506-1514 (2011).
44. Tomiuk, S. et al. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 95, 3638-3643 (1998).
45. Ribeiro, M. F., Zhu, H., Millard, R. W., Fan, G.-C. Exosomes function in pro-and anti-angiogenesis. Curr Angiogenes. 2, 54-59 (2013).
46. Soleimani, M., Nadri, S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 4, 102-106 (2009).
47. Janiszewski, M. et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway. Crit Care Med. 32, 818-825 (2004).